#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small for dates baby Cholangiosarcoma Metastatic gastric cancer Fms-like tyrosine kinase 3 positive Drug eruption Laryngeal squamous cell carcinoma Warm autoimmune haemolytic anaemia Bile acid synthesis disorder Glioblastoma multiforme Haemophagocytic lymphohistiocytosis Glomerulonephritis membranoproliferative Necrotising myositis Non-renal cell carcinoma of kidney Cutaneous calcification Congenital cystic kidney disease More trials…

    Learn about Rare Diseases

    Retinitis pigmentosa – Trials in Disease Glycogen storage disease type II – Basic Information Hereditary hypophosphataemic rickets – Life with Disease Factor IX deficiency – Basic Information Glycogen storage disease type V – Basic Information Lennox-Gastaut syndrome MELAS syndrome – Life with Disease Haemolytic uraemic syndrome – Treatment Mantle cell lymphoma – Trials in Disease Hyperoxaluria More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Glatiramer Acetate Tasquinimod Vx-264 ALN-4324 Ketamine Albaconazole Indacaterol Acetate Mps-102 Abc-23A-116 Dapagliflozin Propanediol ABBV-8736 Pemetrexed Disodium Bt-001 Lorundrostat Indometacin Ph. Eur. Pabinafusp Alfa Specific Nucleic Acid Sna-Veru APAZUNERSEN Dexpanthenol ETX-19477 More therapies…

    Learn about Your Condition

    Diarrhoea Thrombotic microangiopathy Burning mouth syndrome Malignant mast cell neoplasm Endocarditis enterococcal VEXAS syndrome Actinic keratosis Overweight Pancreatic neoplasm Fungal infection Constipation Autoimmune haemolytic anaemia Hand dermatitis Haematological malignancy Hydrocele More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Ocular Physiological Phenomena

  • Study of ONL1204 eye injections to slow vision loss in patients with age-related macular degeneration and geographic atrophy

    Recruiting

    2 1
    Investigated Drugs:
    • XELAFASLATIDE
    Austria Czechia Germany Greece Hungary Italy +3

  • Comparison of hydrocortisone and dexamethasone eye drops for treating inflammatory conjunctival secretions in patients with ocular prostheses

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Hydrocortisone Sodium Phosphate
    • Povidone
    • Dexamethasone Phosphate
    France

  • Study on Brimonidine Eye Drops to Prevent Myopia Progression in Children Aged 6 to 14 Years

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Brimonidine Tartrate
    Spain

  • Study of Darovasertib and Crizotinib for Patients with HLA-A2 Negative Metastatic Uveal Melanoma

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Uveal melanoma
    Investigated Drugs:
    • Crizotinib
    • Darovasertib
    • Dacarbazine
    Belgium

  • Study of Darovasertib and Crizotinib for Patients with Metastatic Uveal Melanoma Who Are HLA-A2 Negative

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    • Crizotinib
    • Darovasertib
    • Dacarbazine
    Belgium France Germany Italy The Netherlands Poland +1

  • Study on the Effectiveness and Safety of STN1010904 Eye Drops for Patients with Fuchs Endothelial Corneal Dystrophy

    Not recruiting

    2 1
    Investigated Diseases:
    • Corneal dystrophy
    Investigated Drugs:
    • Sirolimus
    France
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!